Life Scientist > Biotechnology

Anticancer compound derived from flowers

15 August, 2019

Researchers have produced a compound with anticancer properties directly from the flowering garden plant known as feverfew, which is grown in many UK gardens.


CSL moving to Melbourne Biomedical Precinct

12 August, 2019

Developer PDG will build laboratories and offices to house CSL's global corporate headquarters in the heart of the Melbourne Biomedical Precinct on Elizabeth St, Parkville.


Biologics Innovation Facility opens at UTS

07 August, 2019 by Lauren Davis

The University of Technology Sydney (UTS) has opened the doors of its new Biologics Innovation Facility — a training and production facility that seeks to enable new biotech discoveries as well as to drive the jobs of the future.


Cannabinoids could treat brain tumours

02 August, 2019

MGC Pharmaceuticals has announced preclinical research highlighting the positive impact of using specific cannabinoid formulations in the treatment of glioblastoma.


Natural antibiotics best at combating resistance

30 July, 2019

Natural antibiotics may be more effective than their synthetic counterparts at remaining effective in the wake of antibiotic resistance — although that doesn't mean they can't be given a helping hand.


Pancreas-on-a-chip could help cystic fibrosis patients

29 July, 2019

A human pancreas-on-a-chip, featuring bioengineered human pancreatic organoids, is helping scientists to identify the possible cause of cystic fibrosis-related diabetes.


Cannabis addiction can be treated with… cannabis

26 July, 2019

So-called cannabinoid agonist medication could help tackle dependency on cannabis — a leading cause of drug treatment episodes in Australia.


HIV completely eliminated from mice

24 July, 2019 by Lauren Davis

Using a combination of long-acting drug treatment and gene editing, US researchers claim to have eliminated replication-competent HIV-1 DNA — the virus responsible for AIDS — from the genomes of living animals.


Heart drug could help kids with brain tumours

22 July, 2019

Scientists have discovered that repurposing a heart drug could significantly increase the survival rate for children with ependymoma — a particularly aggressive type of brain tumour.


Hydrogel helps to regenerate cartilage

15 July, 2019

Polyacrylate hydrogels create the support and microenvironment necessary for the growth and maintenance of cartilage cells, and could be optimal candidates for use in clinical practice.


Mass drug administration effective in scabies treatment

04 July, 2019

Two years after the world's first comparative trial of mass drug administration against scabies, the infection rate remained significantly down.


Drug boosts growth in children with dwarfism

01 July, 2019

Tested in a global trial, the drug regulates bone development and boosts growth rates in children with achondroplasia — the most common type of dwarfism.


New drug compound could tackle hereditary kidney disease

01 July, 2019

Mironid has developed a compound to treat autosomal dominant polycystic kidney disease — a hereditary, progressive disease that affects around 12 million people worldwide.


Hypertension drug holds promise for Alzheimer's disease

26 June, 2019

The blood pressure drug nilvadipine increases blood flow to the brain's memory and learning centre among people with Alzheimer's disease without affecting other parts of the brain.


Chemo-free leukaemia treatment approved by FDA

25 June, 2019

A trial into the treatment of chronic lymphocytic leukaemia has been so successful that the US FDA approved the treatment for patients with the disease prior to the trial data being presented.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd